1. Bearing 19q13 aberration predicts poor prognosis in non‐germinal centre type of CD5+DLBCL. (26th October 2017) Authors: Mishima, Yuko; Terui, Yasuhito; Yokoyama, Masahiro; Nishimura, Noriko; Ueda, Kyoko; Kusano, Yoshiharu; Yamauchi, Hirofumi; Inoue, Norihito; Takahashi, Anna; Tsuyama, Naoko; Mishima, Yuji; Takeuchi, Kengo; Hatake, Kiyohiko Journal: British journal of haematology Issue: Volume 183:Number 4(2018) Page Start: 661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate. Issue 5 (31st October 2018) Authors: Mishima, Yuko; Kurano, Makoto; Kobayashi, Tamaki; Nishikawa, Masako; Ohkawa, Ryunosuke; Tozuka, Minoru; Yatomi, Yutaka Journal: Bioscience reports Issue: Volume 38:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of universal vs bedside leukoreductions on the alloimmunization to platelets and the platelet transfusion refractoriness. Issue 1 (February 2015) Authors: Mishima, Yuko; Tsuno, Nelson H.; Matsuhashi, Mika; Yoshizato, Tetsuichi; Sato, Tomohiko; Ikeda, Toshiyuki; Watanabe-Okochi, Naoko; Nagura, Yutaka; Sone, Shinji; Kurokawa, Mineo; Okazaki, Hitoshi Journal: Transfusion and apheresis science Issue: Volume 52:Issue 1(2015) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of universal vs bedside leukoreductions on the alloimmunization to platelets and the platelet transfusion refractoriness. Issue 1 (February 2015) Authors: Mishima, Yuko; Tsuno, Nelson H.; Matsuhashi, Mika; Yoshizato, Tetsuichi; Sato, Tomohiko; Ikeda, Toshiyuki; Watanabe-Okochi, Naoko; Nagura, Yutaka; Sone, Shinji; Kurokawa, Mineo; Okazaki, Hitoshi Journal: Transfusion and apheresis science Issue: Volume 52:Issue 1(2015) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Epstein‐Barr virus‐negative extranodal "true" natural killer‐cell lymphoma harbouring a KDM6A mutation. Issue 1 (10th July 2017) Authors: Tsuyama, Naoko; Asaka, Reimi; Dobashi, Akito; Baba, Satoko; Mishima, Yuko; Ueda, Kyoko; Oguchi, Masahiko; Tsuji, Hideki; Hatake, Kiyohiko; Takeuchi, Kengo Journal: Hematological oncology Issue: Volume 36:Issue 1(2018) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. (3rd April 2013) Authors: Yokoyama, Masahiro; Terui, Yasuhito; Takeuchi, Kengo; Nara, Eriko; Nakano, Kenji; Ueda, Kyoko; Nishimura, Noriko; Mishima, Yuko; Sakajiri, Sakura; Tsuyama, Naoko; Ozawa, Keiya; Hatake, Kiyohiko Other Names: Kildal W. Academic Editor.; Liu Y.-Y. Academic Editor. Journal: ISRN oncology Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Monitoring protein synthesis in single live cancer cells. Issue 5 (9th March 2016) Authors: Tu, Chengyi; Santo, Loredana; Mishima, Yuko; Raje, Noopur; Smilansky, Zeev; Zoldan, Janet Journal: Integrative biology Issue: Volume 8:Issue 5(2016:May) Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era. (October 2020) Authors: Nishimura, Noriko; Takeuchi, Kengo; Asaka, Reimi; Tuyama, Naoko; Inoue, Norihito; Kusano, Yoshiharu; Mishima, Yuko; Yokoyama, Masahiro; Terui, Yasuhito Journal: Leukemia research Issue: Volume 97(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone. Issue 11 (November 2013) Authors: Suzuki, Kazuhito; Terui, Yasuhito; Yokoyama, Masahiro; Ueda, Kyoko; Nishimura, Noriko; Mishima, Yuko; Sakajiri, Sakura; Tsuyama, Naoko; Takeuchi, Kengo; Hatake, Kiyohiko Journal: Leukemia & lymphoma Issue: Volume 54:Issue 11(2013:Nov.) Page Start: 2412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population. Issue 8 (3rd July 2021) Authors: Shirouchi, Yuko; Yokoyama, Masahiro; Fukuta, Takanori; Uryu, Hideki; Nishimura, Noriko; Mishima, Yuko; Inoue, Norihito; Tsuyama, Naoko; Takeuchi, Kengo; Terui, Yasuhito Journal: Leukemia & lymphoma Issue: Volume 62:Issue 8(2021) Page Start: 1869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗